---
figid: PMC8921490__gr11
figtitle: Theranostic F-SLOH mitigates Alzheimer's disease pathology involving TFEB
  and ameliorates cognitive functions in Alzheimer's disease models
organisms:
- Homo sapiens
- Mus musculus
- Agaricus bisporus
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC8921490
filename: gr11.jpg
figlink: /pmc/articles/PMC8921490/figure/fig11/
number: F11
caption: Schematic diagram indicates the mechanism of F-SLOH via activating TFEB and
  promoting autophagy lysosomal pathway.Schematic illustration of the mechanism of
  F-SLOH treatment via activation of TFEB resulting in promotion of autophagy lysosomal
  pathway in vitro and in vivo. Inhibition of MAPK and activation of PP2A is essential
  for F-SLOH-induced TFEB dephosphorylation for nuclear translocation to promote autophagy
  and lysosomal biogenesis in clearance of Aβ.
papertitle: Theranostic F-SLOH mitigates Alzheimer's disease pathology involving TFEB
  and ameliorates cognitive functions in Alzheimer's disease models.
reftext: Ashok Iyaswamy, et al. Redox Biol. 2022 May;51:102280.
year: '2022'
doi: 10.1016/j.redox.2022.102280
journal_title: Redox Biology
journal_nlm_ta: Redox Biol
publisher_name: Elsevier
keywords: Theranostic | Alzheimer's disease | Aβ-targeting | Aβ-aggregate inhibition
  | 3XTg-AD | 5XFAD | Alzheimer's disease, AD | amyloid-β, Aβ | amyloid precursor
  protein, APP | C-terminal fragment 15, CTF15 | Paired helical filaments of Tau,
  PHF1 | transcription factor EB, TFEB | autophagy lysosomal pathway, ALP | neurofibrillary
  tangles, NFTs | tris buffered saline, TBS | phosphate buffered saline, PBS | wild
  type, (WT) mice | cycloheximide, CHX | One-way analysis of variance, ANOVA | fetal
  bovine serum, FBS | nitrocellulose, NC | blood brain barrier, BBB | paraformaldehyde,
  PFA | intra-peritoneally, IP | thioflavin S, ThS | Morris water maze, MWM | contextual
  fear conditioning, CFC | open-field, OF | postsynaptic density protein 95, PSD-95
  | CsA, Cyclosporin A | TG, thapsigargin
automl_pathway: 0.9362279
figid_alias: PMC8921490__F11
figtype: Figure
redirect_from: /figures/PMC8921490__F11
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8921490__gr11.html
  '@type': Dataset
  description: Schematic diagram indicates the mechanism of F-SLOH via activating
    TFEB and promoting autophagy lysosomal pathway.Schematic illustration of the mechanism
    of F-SLOH treatment via activation of TFEB resulting in promotion of autophagy
    lysosomal pathway in vitro and in vivo. Inhibition of MAPK and activation of PP2A
    is essential for F-SLOH-induced TFEB dephosphorylation for nuclear translocation
    to promote autophagy and lysosomal biogenesis in clearance of Aβ.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tfeb
  - Ppp2ca
  - Ppp2r1a
  - alp
  - Alpl
  - Ccl21a
  - Ccl27a
  - Slpi
  - Pdlim3
  - Asrgl1
  - Atrnl1
  - Mapt
  - Csnk1e
  - App
  - H2-Ab1
  - TFEB
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - PTPA
  - ALPP
  - ATHS
  - SLPI
  - CCL27
  - ATRNL1
  - PDLIM3
  - NAT10
  - ASRGL1
  - MAPT
  - APP
  - SUCLA2
  - Mitf
  - MKP-4
  - p38b
  - rl
  - wrd
  - wdb
  - mts
  - tws
  - Pp2A-29B
  - daw
  - Ablp
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - tau
  - ab
  - Appl
---
